Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden?

Lucas GM, Flexner CW, Moore RD.

AIDS Patient Care STDS. 2002 Nov;16(11):527-35. Review.

PMID:
12513901
2.
3.

Targeting candidates for directly administered highly active antiretroviral therapy: benefits observed in HIV-infected injecting drug users in residential drug-rehabilitation facilities.

Babudieri S, Dorrucci M, Boschini A, Carbonara S, Longo B, Monarca R, Ortu F, Congedo P, Soddu A, Maida IR, Caselli F, Madeddu G, Rezza G.

AIDS Patient Care STDS. 2011 Jun;25(6):359-64. doi: 10.1089/apc.2010.0229.

PMID:
21612546
4.

A randomized trial of directly administered antiretroviral therapy and adherence case management intervention.

Wohl AR, Garland WH, Valencia R, Squires K, Witt MD, Kovacs A, Larsen R, Hader S, Anthony MN, Weidle PJ.

Clin Infect Dis. 2006 Jun 1;42(11):1619-27. Epub 2006 Apr 28.

PMID:
16652320
5.

Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups.

Lucas GM, Mullen BA, Weidle PJ, Hader S, McCaul ME, Moore RD.

Clin Infect Dis. 2006 Jun 1;42(11):1628-35. Epub 2006 Apr 28.

PMID:
16652321
6.

Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy.

Lucas GM, Mullen BA, McCaul ME, Weidle PJ, Hader S, Moore RD.

AIDS Patient Care STDS. 2007 Aug;21(8):564-74.

PMID:
17711381
7.

Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study.

Lucas GM, Weidle PJ, Hader S, Moore RD.

Clin Infect Dis. 2004 Jun 1;38 Suppl 5:S409-13.

PMID:
15156431
8.
9.

The costs of HIV antiretroviral therapy adherence programs and impact on health care utilization.

Sansom SL, Anthony MN, Garland WH, Squires KE, Witt MD, Kovacs Andrea A, Larsen RA, Valencia R, Pals SL, Hader S, Weidle PJ, Wohl AR.

AIDS Patient Care STDS. 2008 Feb;22(2):131-8. doi: 10.1089/apc.2006.0216.

PMID:
18260804
10.

Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users.

Smith-Rohrberg D, Mezger J, Walton M, Bruce RD, Altice FL.

J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S48-53.

PMID:
17133204
11.

Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication.

Altice FL, Mezger JA, Hodges J, Bruce RD, Marinovich A, Walton M, Springer SA, Friedland GH.

Clin Infect Dis. 2004 Jun 1;38 Suppl 5:S376-87.

PMID:
15156426
12.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
13.

Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy.

Maru DS, Bruce RD, Walton M, Mezger JA, Springer SA, Shield D, Altice FL.

AIDS Behav. 2008 Mar;12(2):284-93. Epub 2007 Dec 18.

14.

The acceptability of a directly-administered antiretroviral therapy (DAART) intervention among patients in public HIV clinics in Los Angeles, California.

Garland WH, Wohl AR, Valencia R, Witt MD, Squires K, Kovacs A, Larsen R, Potterat N, Anthony MN, Hader S, Weidle PJ.

AIDS Care. 2007 Feb;19(2):159-67.

PMID:
17364394
15.

The feasibility of a community-based directly administered antiretroviral therapy program.

Wohl AR, Garland WH, Squires K, Witt M, Larsen R, Kovacs A, Hader S, Weidle PJ.

Clin Infect Dis. 2004 Jun 1;38 Suppl 5:S388-92.

PMID:
15156427
16.

Does directly administered antiretroviral therapy represent good value for money in sub-Saharan Africa? A cost-utility and value of information analysis.

Uthman RT, Sutton AJ, Jackson LJ, Uthman OA.

PLoS One. 2018 Jan 23;13(1):e0191465. doi: 10.1371/journal.pone.0191465. eCollection 2018.

17.

Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress.

Mitty JA, Stone VE, Sands M, Macalino G, Flanigan T.

Clin Infect Dis. 2002 Apr 1;34(7):984-90. Epub 2002 Feb 27.

PMID:
11880965
18.

Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries.

Friedland G, Abdool Karim S, Abdool Karim Q, Lalloo U, Jack C, Gandhi N, El Sadr W.

Clin Infect Dis. 2004 Jun 1;38 Suppl 5:S421-8.

PMID:
15156433
19.

Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial.

Maru DS, Bruce RD, Walton M, Springer SA, Altice FL.

J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):176-81. doi: 10.1097/QAI.0b013e3181938e7e.

20.

[Directly observed therapy (DOT): from tuberculosis to HIV].

Machouf N, Lalonde RG.

Rev Epidemiol Sante Publique. 2006 Feb;54(1):73-89. Review. French.

PMID:
16609639

Supplemental Content

Support Center